QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
QQQ   280.53 (-0.41%)
AAPL   140.94 (-1.38%)
MSFT   244.37 (-0.31%)
META   113.93 (-0.17%)
GOOGL   94.94 (-2.10%)
AMZN   88.46 (+0.24%)
TSLA   174.04 (-3.21%)
NVDA   161.20 (+0.83%)
NIO   12.58 (-4.98%)
BABA   88.33 (-3.41%)
AMD   70.14 (-0.19%)
T   19.30 (+0.68%)
MU   53.82 (+0.26%)
CGC   3.24 (-10.25%)
F   13.10 (-1.36%)
GE   85.00 (-0.33%)
DIS   92.15 (-0.15%)
AMC   6.05 (-10.37%)
PYPL   74.42 (+3.03%)
PFE   50.24 (+1.07%)
NFLX   308.42 (+0.94%)
NASDAQ:HOLX

Hologic - HOLX Stock Forecast, Price & News

$73.80
-0.42 (-0.57%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$73.48
▼
$74.80
50-Day Range
$60.97
▼
$76.99
52-Week Range
$59.78
▼
$80.49
Volume
1.62 million shs
Average Volume
1.74 million shs
Market Capitalization
$18.14 billion
P/E Ratio
14.41
Dividend Yield
N/A
Price Target
$78.18

Hologic MarketRank™ Forecast

Analyst Rating
Hold
2.46 Rating Score
Upside/​Downside
5.6% Upside
$77.92 Price Target
Short Interest
Bearish
3.39% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.96
Upright™ Environmental Score
News Sentiment
0.21mentions of Hologic in the last 14 days
Based on 8 Articles This Week
Insider Trading
Selling Shares
$3.10 M Sold Last Quarter
Proj. Earnings Growth
12.72%
From $3.46 to $3.90 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.29 out of 5 stars

Medical Sector

308th out of 1,027 stocks

X - Ray Apparatus & Tubes Industry

3rd out of 4 stocks

See Top Rated MarketRank™ Stocks Here
HOLX stock logo

About Hologic (NASDAQ:HOLX) Stock

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

HOLX Stock News Headlines

December 7, 2022 | americanbankingnews.com
Hologic (NASDAQ:HOLX) Now Covered by Analysts at Royal Bank of Canada
December 6, 2022 | finance.yahoo.com
New Data Presented at SABCS 2022 Reveal Expanded Predictive Value of the Breast Cancer Index™ Test for Ovarian Function Suppression in Premenopausal Women with HR+ Breast Cancer
December 6, 2022 | americanbankingnews.com
Brokerages Set Hologic, Inc. (NASDAQ:HOLX) Target Price at $78.18
December 1, 2022 | finance.yahoo.com
Hologic Ranked #1 for Mammography System Performance and Customer Satisfaction for 10th Consecutive Year
November 25, 2022 | finance.yahoo.com
Hologic to Showcase Portfolio of Comprehensive Breast and Skeletal Health Solutions at RSNA 2022
November 22, 2022 | finance.yahoo.com
Hologic to Webcast Presentation at the 5th Annual Evercore ISI HealthCONx Conference
November 17, 2022 | finance.yahoo.com
Hologic Full Year 2022 Earnings: Beats Expectations
November 3, 2022 | finance.yahoo.com
Hologic’s 3Dimensions™ System for 3D Mammography Receives EUREF Type Test Certification
November 3, 2022 | finance.yahoo.com
The Petri Dish: Hologic scores BARDA contract; RA Capital launches neuro startup
November 2, 2022 | finance.yahoo.com
Hologic Announces Contract with BARDA to Support IVD Approval of COVID Assays
November 2, 2022 | finance.yahoo.com
Hologic (HOLX) Q4 Earnings Beat Estimates, Margins Down
November 1, 2022 | finance.yahoo.com
Hologic (HOLX) Beats Q4 Earnings and Revenue Estimates
November 1, 2022 | finance.yahoo.com
Hologic stock jumps, as execs see ‘unprecedented strength’ entering new fiscal year
November 1, 2022 | finance.yahoo.com
Hologic Posts Q4 Earnings Ahead Of Consensus, Sees Unprecedented Strength In 2023
November 1, 2022 | seekingalpha.com
Hologic gains amid positive views from analysts on Q4 results
October 28, 2022 | finance.yahoo.com
Hologic (NASDAQ:HOLX) jumps 7.4% this week, though earnings growth is still tracking behind five-year shareholder returns
October 21, 2022 | finance.yahoo.com
Non-COVID Diagnostics Sales to Aid Hologic (HOLX) Q4 Earnings
October 18, 2022 | finance.yahoo.com
Outlook on the Infectious Disease In Vitro Diagnostics Global Market to 2030 - Featuring BD, Abbott, Quidel and Hologic Among Others - Yahoo Finance
October 18, 2022 | barrons.com
Hologic Stock Got a Huge Boost From Covid. Inside Its Plan to Keep Growing. - Barron's
October 14, 2022 | finance.yahoo.com
An Intrinsic Calculation For Hologic, Inc. (NASDAQ:HOLX) Suggests It's 41% Undervalued
October 14, 2022 | finance.yahoo.com
The global radiology information system market is projected to surpass US$ 1,610 Million by 2028 - Yahoo Finance
October 11, 2022 | nasdaq.com
Hologic (HOLX) Stock Moves -0.03%: What You Should Know - Nasdaq
October 11, 2022 | finance.yahoo.com
Hologic (HOLX) Stock Moves -0.03%: What You Should Know
October 11, 2022 | nasdaq.com
Validea Joel Greenblatt Strategy Daily Upgrade Report - 10/11/2022 - Nasdaq
October 4, 2022 | finance.yahoo.com
Google Cloud Delivers on the Promise of AI and Data Interoperability with New Medical Imaging Suite - Yahoo Finance
See More Headlines
Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

HOLX Company Calendar

Last Earnings
10/31/2022
Today
12/07/2022
Next Earnings (Estimated)
2/01/2023
Fiscal Year End
9/30/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
X - ray apparatus & tubes
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:HOLX
CUSIP
43644010
CIK
859737
Web
www.hologic.com
Phone
(508) 263-2900
Fax
781-890-8031
Employees
6,944
Year Founded
1985

Price Target and Rating

Average Stock Price Forecast
$77.92
High Stock Price Forecast
$86.00
Low Stock Price Forecast
$70.00
Forecasted Upside/Downside
+5.9%
Consensus Rating
Hold
Rating Score (0-4)
2.46
Research Coverage
14 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$5.12
Trailing P/E Ratio
14.41
Forward P/E Ratio
21.33
P/E Growth
1.43
Net Income
$1.30 billion
Net Margins
26.77%
Pretax Margin
32.66%
Return on Equity
31.85%
Return on Assets
16.42%

Debt

Debt-to-Equity Ratio
0.58
Current Ratio
4.12
Quick Ratio
3.45

Sales & Book Value

Annual Sales
$4.86 billion
Price / Sales
3.73
Cash Flow
$7.70 per share
Price / Cash Flow
9.58
Book Value
$19.53 per share
Price / Book
3.78

Miscellaneous

Outstanding Shares
245,834,000
Free Float
242,048,000
Market Cap
$18.14 billion
Optionable
Optionable
Beta
1.02

Social Links


Key Executives

  • Mr. Stephen P. MacMillanMr. Stephen P. MacMillan (Age 58)
    Chairman, CEO & Pres
    Comp: $4.51M
  • Ms. Karleen M. Oberton (Age 51)
    Chief Financial Officer
    Comp: $1.6M
  • Mr. John M. Griffin (Age 61)
    Gen. Counsel
    Comp: $1.56M
  • Mr. Kevin R. ThornalMr. Kevin R. Thornal (Age 48)
    Group Pres of Global Diagnostic Solutions
    Comp: $1.66M
  • Mr. Paul Malenchini
    Chief Information Officer
  • Ryan M. Simon
    VP of Investor Relations
  • Ms. Elisabeth A. Hellmann (Age 53)
    Sr. VP of Global HR & Corp. Communications
  • Mr. Jan VerstrekenMr. Jan Verstreken (Age 54)
    Group Pres of International
  • Ms. Monica Aguirre Berthelot
    VP & Chief of Staff
  • Mr. Mike Kelly
    Chief Supply Chain Officer and Corp. VP of Quality Assurance & Regulatory Affairs

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













HOLX Stock - Frequently Asked Questions

Should I buy or sell Hologic stock right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last twelve months. There are currently 8 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HOLX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HOLX, but not buy additional shares or sell existing shares.
View HOLX analyst ratings or view top-rated stocks.

What is Hologic's stock price forecast for 2023?

14 Wall Street research analysts have issued 12 month price objectives for Hologic's stock. Their HOLX share price forecasts range from $70.00 to $86.00. On average, they predict the company's share price to reach $77.92 in the next twelve months. This suggests a possible upside of 5.2% from the stock's current price.
View analysts price targets for HOLX or view top-rated stocks among Wall Street analysts.

How have HOLX shares performed in 2022?

Hologic's stock was trading at $76.56 at the beginning of the year. Since then, HOLX shares have decreased by 3.3% and is now trading at $74.05.
View the best growth stocks for 2022 here.

When is Hologic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our HOLX earnings forecast.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) released its quarterly earnings data on Monday, October, 31st. The medical equipment provider reported $0.82 EPS for the quarter, beating the consensus estimate of $0.62 by $0.20. The medical equipment provider earned $953.30 million during the quarter, compared to analysts' expectations of $861.68 million. Hologic had a trailing twelve-month return on equity of 31.85% and a net margin of 26.77%. The business's quarterly revenue was down 27.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.61 earnings per share.
Read the conference call transcript.

What guidance has Hologic issued on next quarter's earnings?

Hologic updated its first quarter 2023 earnings guidance on Monday, November, 7th. The company provided earnings per share guidance of $0.80-$0.90 for the period, compared to the consensus estimate of $0.82. The company issued revenue guidance of $940.00 million-$990.00 million, compared to the consensus revenue estimate of $965.85 million.

What is Steve MacMillan's approval rating as Hologic's CEO?

447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

What is Hologic's stock symbol?

Hologic trades on the NASDAQ under the ticker symbol "HOLX."

Who are Hologic's major shareholders?

Hologic's stock is owned by many different retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.38%), BlackRock Inc. (9.37%), State Street Corp (4.63%), Price T Rowe Associates Inc. MD (2.91%), Macquarie Group Ltd. (2.34%) and Victory Capital Management Inc. (1.71%). Insiders that own company stock include Benjamin Jordan Cohn, Jan Verstreken, John M Griffin, Karleen Marie Oberton, Kevin R Thornal, Peter J Valenti III, Sally Crawford, Sean S Daugherty, Sean S Daugherty and Stephen P Macmillan.
View institutional ownership trends.

How do I buy shares of Hologic?

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Hologic's stock price today?

One share of HOLX stock can currently be purchased for approximately $74.05.

How much money does Hologic make?

Hologic (NASDAQ:HOLX) has a market capitalization of $18.20 billion and generates $4.86 billion in revenue each year. The medical equipment provider earns $1.30 billion in net income (profit) each year or $5.12 on an earnings per share basis.

How many employees does Hologic have?

The company employs 6,944 workers across the globe.

Does Hologic have any subsidiaries?
The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More
How can I contact Hologic?

Hologic's mailing address is 250 CAMPUS DRIVE, MARLBOROUGH MA, 01752. The official website for the company is www.hologic.com. The medical equipment provider can be reached via phone at (508) 263-2900, via email at michael.watts@hologic.com, or via fax at 781-890-8031.

This page (NASDAQ:HOLX) was last updated on 12/7/2022 by MarketBeat.com Staff